Publications by authors named "Hongmian Jiang"
Article Synopsis
- Primary hepatic neuroendocrine carcinoma (PHNEC) is a rare liver tumor with non-specific symptoms and unclear treatment standards.
- A case study of a 53-year-old male in China highlighted successful treatment using hepatic arterial infusion chemotherapy (HAIC) combined with camrelizumab and apatinib, resulting in a significant reduction of tumor size.
- This combination therapy may offer a promising approach for managing advanced PHNEC, although more research is required to establish standardized treatment protocols.
Background: The Forkhead box M1 factor (FOXM1) is a crucial activator for cancer cell proliferation. While FOXM1 has been shown to promote hepatocellular carcinoma (HCC) progression, its transcriptional mechanisms remain incompletely understood.
Methods: We performed an in-house tissue microarray on 313 HCC and 37 non-HCC tissue samples, followed by immunohistochemical staining.
Background: Heterotopic ossification (HO) is noted most frequently in periarticular muscles and has not yet been reported in the cruciate ligaments of the knee. We present a rare case of symptomatic ossification of the posterior cruciate ligament (PCL).
Case Presentation: A 59-year-old woman had a 2-year history of knee pain that was getting worse during knee motion and had restricted knee motion for 1 year.
Resveratrol (RSV) is known to possess anticancer properties in many types of cancers like breast cancer, in which POLD1 may serve as a potential target. However, the anticancer mechanism of RSV on triple negative breast cancer (TNBC) remains unclear. In the present study, the antitumor effects and mechanism of RSV on TNBC cells were analyzed by RNA sequencing (RNA-seq), which was then verified cell counting kit-8 (CCK8), immunofluorescence, immunohistochemistry, Western Blot (WB), flow cytometry, and hematoxylin-eosin (HE) staining.
View Article and Find Full Text PDF